Acrivon Therapeutics, Correlations

ACRV Stock

2.52 0.09 3.45%

The current 90-days correlation between Acrivon Therapeutics, and Aerovate Therapeutics is 0.13 (i.e., Average diversification). The correlation of Acrivon Therapeutics, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Acrivon Therapeutics, Correlation With Market

Modest diversification

The correlation between Acrivon Therapeutics, Common and DJI is 0.26 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acrivon Therapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Moving together with Acrivon Stock

0.62	ELVN	Enliven Therapeutics	Pair Corr
0.63	CRNX	Crinetics Pharmaceuticals	Pair Corr

Moving against Acrivon Stock

0.58	LUCD	Lucid Diagnostics	Pair Corr
0.51	WM	Waste Management	Pair Corr
0.49	GE	GE Aerospace	Pair Corr
0.37	PLX	Protalix Biotherapeutics	Pair Corr
0.66	CVX	Chevron Corp	Pair Corr
0.58	XOM	Exxon Mobil Corp Earnings Call This Week	Pair Corr
0.52	T	ATT Inc Aggressive Push	Pair Corr
0.5	MMM	3M Company	Pair Corr
0.49	JNJ	Johnson Johnson	Pair Corr
0.45	INTC	Intel	Pair Corr
0.41	CSCO	Cisco Systems Aggressive Push	Pair Corr
0.33	IBM	International Business	Pair Corr

Related Correlations Analysis

	AVTE	ADAG	RZLT	ANTX	ANEB	PMVP	MOLN	MLYS	ANAB	OPT
AVTE		0.03	0.42	0.37	0.43	0.46	0.22	0.23	-0.43	-0.55	AVTE
ADAG	0.03		0.18	-0.09	-0.52	0.35	0.24	-0.24	-0.17	0.12	ADAG
RZLT	0.42	0.18		-0.53	0.11	0.79	0.74	-0.67	-0.32	0.2	RZLT
ANTX	0.37	-0.09	-0.53		0.39	-0.28	-0.4	0.85	-0.18	-0.81	ANTX
ANEB	0.43	-0.52	0.11	0.39		0.05	-0.09	0.38	-0.1	-0.48	ANEB
PMVP	0.46	0.35	0.79	-0.28	0.05		0.61	-0.4	-0.44	-0.01	PMVP
MOLN	0.22	0.24	0.74	-0.4	-0.09	0.61		-0.7	-0.36	0.03	MOLN
MLYS	0.23	-0.24	-0.67	0.85	0.38	-0.4	-0.7		0.04	-0.6	MLYS
ANAB	-0.43	-0.17	-0.32	-0.18	-0.1	-0.44	-0.36	0.04		0.36	ANAB
OPT	-0.55	0.12	0.2	-0.81	-0.48	-0.01	0.03	-0.6	0.36		OPT
	AVTE	ADAG	RZLT	ANTX	ANEB	PMVP	MOLN	MLYS	ANAB	OPT

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

MLYS	+ 0.85	ANTX
PMVP	+ 0.79	RZLT
MOLN	+ 0.74	RZLT
MOLN	+ 0.61	PMVP
PMVP	+ 0.46	AVTE
ANEB	+ 0.43	AVTE

High negative correlations

OPT	- 0.81	ANTX
MLYS	- 0.7	MOLN
MLYS	- 0.67	RZLT
OPT	- 0.6	MLYS
OPT	- 0.55	AVTE
ANTX	- 0.53	RZLT

Risk-Adjusted Indicators

There is a big difference between Acrivon Stock performing well and Acrivon Therapeutics, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Acrivon Therapeutics,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
AVTE	1.31	(0.03)	0.00	1.68	0.00	0.00	2.07	(3.27)	10.45
ADAG	2.63	(0.25)	0.00	0.33	0.00	0.00	4.62	(7.34)	18.68
RZLT	3.07	(0.53)	0.00	(0.53)	0.00	0.00	5.62	(6.49)	22.04
ANTX	2.34	0.26	0.10	0.42	2.29	(2.93)	5.41	(3.85)	17.09
ANEB	5.64	0.67	0.11	0.48	5.52	(8.12)	19.58	(10.43)	48.29
PMVP	1.88	(0.35)	0.00	(0.35)	0.00	0.00	4.41	(3.65)	16.42
MOLN	2.82	(0.23)	0.00	(0.12)	0.00	0.00	7.91	(7.39)	20.58
MLYS	4.34	0.70	0.15	(0.38)	4.20	(5.13)	10.04	(8.23)	50.53
ANAB	4.31	0.44	0.10	0.27	4.33	(5.50)	9.84	(7.48)	43.41
OPT	4.37	0.10	0.01	0.09	6.72	(4.61)	8.61	(7.55)	44.59

Acrivon Therapeutics, Corporate Management

Peter MD	Chairman, CoFounder	Profile
Jesper Olsen	Head CoFounder	Profile
Dr MBA	Senior Affairs	Profile
Katharine CPA	Vice Accounting	Profile
Bruce Close	Vice Compliance	Profile
MaryAlice JD	Chief Officer	Profile
Crystal Mercado	Global HR	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC